Across TCGA pan-cancer cohorts, HEATR6 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated HEATR6 data layer compared with 26 for mass-spec protein and 7 for mutation status.
The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher HEATR6 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated HEATR6 expression acts as an unfavorable survival marker.
CCRCC, PDAC, and LSCC are the cancer types where HEATR6 mass-spec protein most reproducibly stratifies survival.